Search by Drug Name or NDC

    NDC 50742-0252-30 diltiazem hydrochloride 360 mg/1 Details

    diltiazem hydrochloride 360 mg/1

    diltiazem hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ingenus Pharmaceuticals, LLC. The primary component is DILTIAZEM HYDROCHLORIDE.

    Product Information

    NDC 50742-0252
    Product ID 50742-252_6c087cf6-74bb-4427-b816-94058d003414
    Associated GPIs 34000010127060
    GCN Sequence Number 032600
    GCN Sequence Number Description diltiazem HCl CAP ER 24H 360 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 07460
    HICL Sequence Number 000182
    HICL Sequence Number Description DILTIAZEM HCL
    Brand/Generic Generic
    Proprietary Name diltiazem hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name diltiazem hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 360
    Active Ingredient Units mg/1
    Substance Name DILTIAZEM HYDROCHLORIDE
    Labeler Name Ingenus Pharmaceuticals, LLC
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208783
    Listing Certified Through 2024-12-31

    Package

    NDC 50742-0252-30 (50742025230)

    NDC Package Code 50742-252-30
    Billing NDC 50742025230
    Package 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-252-30)
    Marketing Start Date 2019-06-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.26378
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DILTIAZEM 24H ER(CD) 360 MG CP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis